- Home
- FENC vs TEAF Comparison
FENC vs TEAF Comparison
Compare FENC & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- TEAF
- Stock Information
- Founded
- FENC 1996
- TEAF 2017
- Country
- FENC United States
- TEAF United States
- Employees
- FENC N/A
- TEAF N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- TEAF Trusts Except Educational Religious and Charitable
- Sector
- FENC Health Care
- TEAF Finance
- Exchange
- FENC Nasdaq
- TEAF Nasdaq
- Market Cap
- FENC 156.9M
- TEAF 174.8M
- IPO Year
- FENC 2001
- TEAF N/A
- Fundamental
- Price
- FENC $5.54
- TEAF $12.33
- Analyst Decision
- FENC Strong Buy
- TEAF
- Analyst Count
- FENC 2
- TEAF 0
- Target Price
- FENC $14.00
- TEAF N/A
- AVG Volume (30 Days)
- FENC 73.5K
- TEAF 56.1K
- Earning Date
- FENC 11-07-2024
- TEAF 01-01-0001
- Dividend Yield
- FENC N/A
- TEAF 9.20%
- EPS Growth
- FENC N/A
- TEAF N/A
- EPS
- FENC N/A
- TEAF N/A
- Revenue
- FENC $49,348,000.00
- TEAF N/A
- Revenue This Year
- FENC $170.43
- TEAF N/A
- Revenue Next Year
- FENC $6.70
- TEAF N/A
- P/E Ratio
- FENC N/A
- TEAF N/A
- Revenue Growth
- FENC 278.09
- TEAF N/A
- 52 Week Low
- FENC $3.96
- TEAF $11.11
- 52 Week High
- FENC $11.49
- TEAF $13.30
- Technical
- Relative Strength Index (RSI)
- FENC 40.02
- TEAF 57.73
- Support Level
- FENC $5.61
- TEAF $11.84
- Resistance Level
- FENC $6.19
- TEAF $12.21
- Average True Range (ATR)
- FENC 0.26
- TEAF 0.14
- MACD
- FENC -0.10
- TEAF 0.05
- Stochastic Oscillator
- FENC 6.42
- TEAF 95.54
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Essential Assets Income Term is a US-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.